KLP Kapitalforvaltning AS purchased a new position in Solventum Co. (NYSE:SOLV - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 51,565 shares of the company's stock, valued at approximately $3,406,000.
A number of other hedge funds also recently bought and sold shares of SOLV. Hotchkis & Wiley Capital Management LLC bought a new stake in shares of Solventum in the 3rd quarter valued at approximately $125,488,000. Trian Fund Management L.P. lifted its position in Solventum by 32.9% in the third quarter. Trian Fund Management L.P. now owns 7,126,255 shares of the company's stock worth $496,842,000 after buying an additional 1,765,676 shares during the last quarter. Boston Partners purchased a new position in Solventum during the fourth quarter worth $110,378,000. Point72 Asset Management L.P. bought a new position in Solventum during the third quarter valued at $50,948,000. Finally, Nordea Investment Management AB raised its stake in shares of Solventum by 189.5% in the fourth quarter. Nordea Investment Management AB now owns 659,887 shares of the company's stock valued at $43,902,000 after acquiring an additional 431,986 shares during the period.
Wall Street Analysts Forecast Growth
A number of equities analysts recently commented on SOLV shares. Piper Sandler lifted their price target on shares of Solventum from $75.00 to $84.00 and gave the stock a "neutral" rating in a research note on Friday, February 28th. Bank of America boosted their target price on Solventum from $80.00 to $85.00 and gave the company a "neutral" rating in a research report on Wednesday, February 26th. Morgan Stanley increased their price target on Solventum from $73.00 to $80.00 and gave the stock an "equal weight" rating in a report on Wednesday, March 5th. Wells Fargo & Company boosted their price objective on Solventum from $73.00 to $75.00 and gave the company an "equal weight" rating in a report on Friday, February 28th. Finally, The Goldman Sachs Group increased their target price on Solventum from $63.00 to $71.00 and gave the stock a "sell" rating in a research note on Monday, March 3rd. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $79.86.
View Our Latest Report on Solventum
Solventum Stock Down 1.0 %
NYSE SOLV traded down $0.73 on Friday, reaching $74.78. 1,933,229 shares of the stock traded hands, compared to its average volume of 1,475,014. Solventum Co. has a 12 month low of $47.16 and a 12 month high of $85.92. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15. The company has a fifty day moving average price of $75.51 and a 200-day moving average price of $71.87. The company has a market cap of $12.94 billion and a price-to-earnings ratio of 27.19.
About Solventum
(
Free Report)
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
See Also
Before you consider Solventum, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Solventum wasn't on the list.
While Solventum currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
